Brief: Clinigen and Onxeo initiate managed access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL)

Valerio Therapeutics SA

24/04/2017 17:31

April 24 (Reuters) - Onxeo SA  C4X.PA : 
    * Clinigen and co initiate managed access programme for belinostat in Europe for patients 
with peripheral T-cell lymphoma (PTCL) 
 
Source text for Eikon:  ID:nBw79fCvXa  
Further company coverage:  C4X.PA  
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))